Immunotherapeutic Use Expanded to Head and Neck Cancer
The U.S. Food and Drug Administration decision means nivolumab is now an approved treatment for five types of cancer....
The U.S. Food and Drug Administration decision means nivolumab is now an approved treatment for five types of cancer....
Adding the newly approved therapeutic to standard treatment improved survival for patients with advanced disease. The U.S. Food and...
The U.S. Food and Drug Administration approval means there are now three immunotherapeutics called checkpoint inhibitors approved for treating...
The U.S. Food and Drug Administration approval provides a new treatment option for patients with the most common type...
The FDA-approved diagnostic test uses blood samples to look for specific mutations in certain patients with metastatic lung cancer....
The approval provides the first new treatment option in more than 30 years for patients with the most common...
The U.S. Food and Drug Administration approval provides a new option for patients with the most common type of...
The U.S. Food and Drug Administration approval provides a new option for patients with the most common type of...
The U.S. Food and Drug Administration approval increases the number of patients with lung cancer for whom afatinib (Gilotrif)...
The newly approved therapeutic improved survival for patients with the most common type of kidney cancer compared with standard...